Trident Lifeline Reports Strong Q3 FY24-25 Results, Signaling Growth in Pharmaceuticals Sector

Jan 22 2025 07:31 PM IST
share
Share Via
Trident Lifeline has reported strong financial results for the third quarter of FY24-25, with a Profit After Tax of Rs 6.42 crore, reflecting a year-on-year growth of 106.43%. Net sales for the half-year reached Rs 32.17 crore, indicating a significant increase of 73.24% year-on-year, showcasing the company's operational efficiency and market presence.
Trident Lifeline, a microcap player in the pharmaceuticals and drugs industry, has reported encouraging financial results for the third quarter of FY24-25. The company declared its financial performance on January 22, 2025, showcasing significant growth in key metrics.

For the half-year period, Trident Lifeline achieved a Profit After Tax (PAT) of Rs 6.42 crore, reflecting an impressive year-on-year growth of 106.43%. This positive trend indicates robust financial health and operational efficiency within the company. Additionally, the net sales for the same period reached Rs 32.17 crore, marking a substantial increase of 73.24% year-on-year. This surge in sales underscores the company's strong market presence and effective business strategies.

There has been an adjustment in evaluation, with Trident Lifeline's score reflecting a shift from 26 to 16 over the past three months. Nevertheless, the company's financial indicators suggest a solid performance trajectory. The recent results highlight Trident Lifeline's commitment to growth and innovation in the competitive pharmaceuticals sector, positioning it favorably in the market landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News